Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Philippines sheds over 1%; others wary before U.S. tariff deadline

2018-07-05 theedgemarkets
(July 5): Philippine shares fell more than 1% on Thursday, after the country's June inflation hit an over five-year high, while other markets in the region were subdued on caution ahead of Friday's deadline for further U.S. tariffs on Chinese goods.
SMIVY U14 SVTMF UOLGF SGAPY SM UOLGY COL SNGNF

21
‘Buy’ for bank stocks following Q1 sell-off

2018-05-27 bworldonline
THE GROWTH of banking stocks slowed during the quarter as market volatility sent investors into profit-taking mode despite the sector’s good earnings reports. For this quarter, however, most analysts interviewed have signaled a “buy” on the sector amid expectations of better earnings in the months ahead.
EW UBNC PSKXF CHIB BDOUY RZLLY PBB RCB SECB CKGOY AUB BDOUF BDO SYBJF PNB PHSXY PSE COL PTC

0
Sales of sugar-sweetened drinks slump in Feb. amid higher taxes

2018-04-18 bworldonline
ALREADY REELING from a shift in consumer preference to healthier options, sales of sugar-sweetened beverages weakened in February following the implementation of higher excise taxes, according to performance management company Nielsen.
COL

1
Firms see robust sales despite TRAIN

2018-04-15 bworldonline
FILIPINOS did not hold back on spending despite higher prices of goods in the first quarter of the year, but elevated input costs would continue to put pressure on the profitability of consumer companies.
PGCMF SEVN PHSVY PRGLY COL PGOLD

22
Shares fall ahead of Lenten break

2018-03-28 bworldonline
The main index lost 0.83% or 67.20 points to close at 7,979.83, slumping back below the 8,000 level after a temporary recovery on Tuesday.
MER SVTMF PSKXF GTMEY SM GLOPP GLO SMIVY PHSXY GTMEF PSE COL GLOPA

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to PSE:COL / COL Financial Group, Inc. on message board site Silicon Investor.

The Financial Collapse of 2001 Unwinding The *NEW* Frank Coluccio Technology Forum
Ratu0027s Nest - Chronicles of Collapse Observations and Collectables
Effective Collaboration - Team Research for Better Returns: GUMM - Eliminate the Common Cold
2018 NCAA College Basketball March Madness 2017 NCAA College Basketball March Madness
Gran Colombia Resources Inc (TSE.GRM) 2016 NCAA College Basketball March Madness